A Case Study on Diabetic Neuropathy

Authors

  • Kanamala Arun Chand Roby Department of Pharmacy Practice, Ratnam Institute of Pharmacy, Pidathapolur (V), Muthukur (M), SPSR Nellore-524 346, Andhra Pradesh, India https://orcid.org/0000-0003-0326-4215
  • Priyanka Singamsetty Narayana Medical College and Hospital, Chinthareddy Palem, SPSR Nellore-524 346, Andhra Pradesh, India https://orcid.org/0000-0002-1727-7917
  • Gundra Tejaswi Narayana Medical College and Hospital, Chinthareddy Palem, SPSR Nellore-524 346, Andhra Pradesh, India https://orcid.org/0000-0001-5449-2942
  • Avula Sai Poojitha Narayana Medical College and Hospital, Chinthareddy Palem, SPSR Nellore-524 346, Andhra Pradesh, India https://orcid.org/0000-0001-9626-5772
  • Likitha K Narayana Medical College and Hospital, Chinthareddy Palem, SPSR Nellore-524 346, Andhra Pradesh, India https://orcid.org/0000-0002-2944-0654
  • Kudipudi Harinadha Baba Department of Pharmaceutical Analysis, Narayana Pharmacy College, Chinthareddy Palem, SPSR Nellore-524 346, Andhra Pradesh, India

DOI:

https://doi.org/10.26452/fjphs.v2i4.318

Abstract

For the past nine years, a 54-year-old woman has had decreased glucose tolerance. A low dose of an angiotensin-converting enzyme inhibitor is used to treat her sole other medical problem, hypertension (ACE) & Metformin + Vilgagliptin 50/500mg. She has had a stress ECG every two years, and the results have always been fine. During normal lab tests, she had a positive result for glucose intolerance. The first step in treating diabetic neuropathy is glucose control once the condition has been identified. Rigid insulin management dramatically decreased the likelihood of developing neuropathy, according to research by the Diabetes Complications and Control Trial Research Group. Even in patients with "excellent" blood glucose control, stricter management may result in improvements or a slowdown of the progression of neuropathy symptoms. Her vitamin B12 levels were found to be insufficient. She was taking a vitamin supplement containing folate, therefore there was no indication that she had macrocytic anemia. B12 therapy started for the patient. She claimed that although her neurological issues had only somewhat improved after 4 months of therapy.

Keywords:

Diabetic Neuropathy, Glucose Tolerance, Neurological Issues, Diabetes Mellitus (DM), Blood Glucose Levels

Downloads

Download data is not yet available.

Published

2022-09-19

How to Cite

Kanamala Arun Chand Roby, Priyanka Singamsetty, Gundra Tejaswi, Avula Sai Poojitha, Likitha K, & Kudipudi Harinadha Baba. (2022). A Case Study on Diabetic Neuropathy. Future Journal of Pharmaceuticals and Health Sciences, 2(4), 283–287. https://doi.org/10.26452/fjphs.v2i4.318

Issue

Section

Case Report

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)